Loading AI feed…
Twist Bioscience
Action, confidence, horizon, and decision blockers at a glance.
Fast scan of bull, bear, and watch items
High-level snapshot
Thesis highlights from the latest analysis
Scannable catalysts and supporting factors
Other notable items detected
Next few weeks
Months to a year
| Symbol | Summary |
|---|---|
| DHR | Danaher is a relevant operating comp because Twist identifies Integrated DNA Technologies, a Danaher business, as a competitor in core synthetic biology products and NGS sample-preparation workflows; DHR’s scale underscores the competitive pressure Twist faces on price, service, and manufacturing depth [#10-K-2025-11-17]. |
| TMO | Thermo Fisher is a direct competitive benchmark in both gene synthesis through GeneArt and in NGS sample-preparation tools, making it a useful large-cap comp for evaluating whether Twist’s revenue growth is enough to offset its weaker profitability profile [#10-K-2025-11-17]. |
| ILMN | Illumina is not a full business-model match, but Twist cites it as a competitor in NGS-focused sample-preparation markets; that makes ILMN a relevant read-through for platform adoption and competitive intensity in genomics workflows [#10-K-2025-11-17]. |
Internal and external references used in this analysis